Views | |
---|---|
Efficacy and safety of golimumab as add-on therapy to standard disease-modifying antirheumatic drugs : results of the GO-MORE study in the Polish population | 60 |
listopada 2021 | grudnia 2021 | stycznia 2022 | lutego 2022 | marca 2022 | kwietnia 2022 | maja 2022 | |
---|---|---|---|---|---|---|---|
Efficacy and safety of golimumab as add-on therapy to standard disease-modifying antirheumatic drugs : results of the GO-MORE study in the Polish population | 3 | 2 | 1 | 1 | 0 | 2 | 1 |
Views | |
---|---|
korkosz_et-al_efficacy_andsafety_of_golimumab_as_add-on_therapy_2018.pdf | 65 |
korkosz_et-al_efficacy_andsafety_of_golimumab_as_add-on_therapy_2018.odt | 3 |
Views | |
---|---|
United States | 39 |
Poland | 4 |
Germany | 3 |
Vietnam | 3 |
Malaysia | 1 |
Views | |
---|---|
Ashburn | 24 |
Fairfield | 4 |
Hanoi | 3 |
Woodbridge | 3 |
Chorzelow | 2 |
Seattle | 2 |
Cambridge | 1 |
Des Moines | 1 |
Kraków | 1 |
Kuala Lumpur | 1 |